On 11 December HomeAway, Inc. (NASDAQ:AWAY) announced an initiative to enable online booking for HomeAway property listings over the next 24 months. Once these changes are adopted, listings on HomeAway’s sites will reflect accurate calendars and rates, the ability to submit a reservation request with one click, and the ability for owners and property managers to accept or reject a reservation within 24 hours. HomeAway, Inc. (NASDAQ:AWAY) in last trading activity increased 2.73% to close at $29.78. Company weekly performance is 3.33% while its quarterly performance stands at -14.62%. HomeAway, Inc. (NASDAQ:AWAY) is -39.10% away from its 52 week high.
Seattle Genetics Inc (NASDAQ:SGEN) Director Felix Baker purchased 2,883,378 shares of Seattle Genetics stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average cost of $31.86 per share, for a total transaction of $91,864,423.08. Following the acquisition, the director now directly owns 107,504 shares of the company’s stock, valued at approximately $3,425,077. On Wednesday shares of Seattle Genetics Inc. (NASDAQ:SGEN) closed at $32.13. Company’s sales growth for last 5 years was 50.20% and EPS growth for next 5 years is recorded as 10.10%.
On 22 December MacroGenics, Inc. (NASDAQ:MGNX) announced a global collaboration and license agreement for MGD011 with Janssen Biotech, Inc. This product candidate incorporates MacroGenics’ proprietary platform for Dual-Affinity Re-Targeting (DART®) to simultaneously target CD19 and CD3 for the potential treatment of B-cell malignancies. MacroGenics, Inc. (NASDAQ:MGNX) has 0.40% insider ownership while its institutional ownership stands at 73.00%. In last trading activity company’s stock closed at $35.07.
On 30 December Astea International Inc. (NASDAQ:ATEA) announced that it has been positioned in the Visionaries Quadrant in Gartner’s 2014 Magic Quadrant for Field Service Management*. On last trading day Astea International Inc. (NASDAQ:ATEA) moved up 8.70% to close at $1.75. Its volatility for the week is 12.17% while volatility for the month is 8.71%. ATEA’s sales growth for past 5 years was -3.20% and its EPS growth for past 5 years was -0.40%. Astea International Inc. (NASDAQ:ATEA) monthly performance is 40.00%.
On 16 December Opko Health, Inc. (NYSE:OPK) said that Pfizer Inc. (NYSE:PFE) has inked a licensing agreement with Opko Health Inc. (NYSE:OPK) over the latter’s long-acting human growth hormone (hGH-CTP). On last trading day Opko Health, Inc. (NYSE:OPK) increased 1.42% to close at $9.99. Its volatility for the week is 2.14% while volatility for the month is 3.12%. OPK’s sales growth for past 5 years was 59.30% and its EPS growth for past 5 years was -8.80%. Opko Health, Inc. (NYSE:OPK) monthly performance is 20.94%.